10x Genomics (TXG) Reports Q2 Earnings: What Key Metrics Have to Say

For the quarter ended June 2025, 10x Genomics (TXG) reported revenue of $172.91 million, up 12.9% over the same period last year. EPS came in at $0.28, compared to -$0.32 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $139.44 million, representing a surprise of +24%. The company delivered an EPS surprise of +180%, with the consensus EPS estimate being -$0.35.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street ...